Krystal Biotech Inc (KRYS)
170.85
-5.54
(-3.14%)
USD |
NASDAQ |
Nov 04, 16:00
171.06
+0.21
(+0.12%)
After-Hours: 20:00
Krystal Biotech Market Cap: 4.909B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 4.909B |
| November 01, 2024 | 5.068B |
| October 31, 2024 | 4.957B |
| October 30, 2024 | 5.043B |
| October 29, 2024 | 5.063B |
| October 28, 2024 | 5.082B |
| October 25, 2024 | 5.042B |
| October 24, 2024 | 5.027B |
| October 23, 2024 | 4.963B |
| October 22, 2024 | 5.033B |
| October 21, 2024 | 5.142B |
| October 18, 2024 | 5.148B |
| October 17, 2024 | 5.080B |
| October 16, 2024 | 5.108B |
| October 15, 2024 | 5.127B |
| October 14, 2024 | 5.159B |
| October 11, 2024 | 5.134B |
| October 10, 2024 | 4.975B |
| October 09, 2024 | 4.941B |
| October 08, 2024 | 5.023B |
| October 07, 2024 | 5.028B |
| October 04, 2024 | 5.088B |
| October 03, 2024 | 5.054B |
| October 02, 2024 | 5.096B |
| October 01, 2024 | 5.214B |
| Date | Value |
|---|---|
| September 30, 2024 | 5.230B |
| September 27, 2024 | 5.089B |
| September 26, 2024 | 5.126B |
| September 25, 2024 | 5.158B |
| September 24, 2024 | 5.156B |
| September 23, 2024 | 5.177B |
| September 20, 2024 | 5.291B |
| September 19, 2024 | 5.300B |
| September 18, 2024 | 5.250B |
| September 17, 2024 | 5.437B |
| September 16, 2024 | 5.581B |
| September 13, 2024 | 5.791B |
| September 12, 2024 | 5.621B |
| September 11, 2024 | 5.711B |
| September 10, 2024 | 5.315B |
| September 09, 2024 | 5.392B |
| September 06, 2024 | 5.292B |
| September 05, 2024 | 5.346B |
| September 04, 2024 | 5.342B |
| September 03, 2024 | 5.366B |
| August 30, 2024 | 5.606B |
| August 29, 2024 | 5.609B |
| August 28, 2024 | 5.858B |
| August 27, 2024 | 5.695B |
| August 26, 2024 | 5.761B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
607.87M
Minimum
Mar 18 2020
6.134B
Maximum
Jul 26 2024
2.222B
Average
1.751B
Median
Market Cap Benchmarks
| Bioventus Inc | 892.20M |
| ADMA Biologics Inc | 4.454B |
| Axsome Therapeutics Inc | 4.183B |
| Amicus Therapeutics Inc | 3.362B |
| Sarepta Therapeutics Inc | 11.74B |
Market Cap Related Metrics
| PE Ratio | 46.74 |
| PS Ratio | 30.02 |
| Price to Book Value | 5.858 |
| Price | 170.85 |
| Earnings Yield | 2.14% |
| Operating PE Ratio | 1239.03 |
| Normalized PE Ratio | 102.30 |